1. ABO Blood Groups and Coronavirus Disease 2019 (COVID-19). (28th September 2020) Authors: Delanghe, Joris R; De Buyzere, Marc L; Speeckaert, Marijn M Journal: Clinical infectious diseases Issue: Volume 72:Number 11(2021) Page Start: e917 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. C3 and ACE1 polymorphisms are more important confounders in the spread and outcome of COVID-19 in comparison with ABO polymorphism. (1st August 2020) Authors: Delanghe, Joris R; De Buyzere, Marc L; Speeckaert, Marijn M Journal: European journal of preventive cardiology Issue: Volume 27:Number 12(2020) Page Start: 1331 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. C3 and ACE1 polymorphisms are more important confounders in the spread and outcome of COVID-19 in comparison with ABO polymorphism. (August 2020) Authors: Delanghe, Joris R; De Buyzere, Marc L; Speeckaert, Marijn M Journal: European journal of preventive cardiology Issue: Volume 27:Number 12(2020) Page Start: 1331 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Contribution of Vitamin D–Binding Protein Polymorphism to Susceptibility and Outcome of COVID-19 Patients. Issue 8 (7th August 2021) Authors: Speeckaert, Marijn M; Delanghe, Joris R Journal: Journal of nutrition Issue: Volume 151:Issue 8(2021) Page Start: 2498 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Importance of the Lipid-Bound Character of Vitamin D Binding Protein in the Evaluation of Vitamin D Status in COVID-19 Patients. Issue 5 (5th January 2021) Authors: Speeckaert, Marijn M; Delanghe, Joris R Journal: American journal of clinical pathology Issue: Volume 155:Issue 5(2021) Page Start: 766 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Letters to the editor: Vitamin D binding protein in COVID-19. Issue 5 (2020) Authors: Speeckaert, Marijn M; Speeckaert, Reinhart; Delanghe, Joris R Journal: Clinical medicine Issue: Volume 20:Issue 5(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Optimal Use of Biomarkers for Chronic Kidney Disease. (1st August 2019) Authors: Miller, W Greg; Bachmann, Lorin M; Delanghe, Joris R; Inker, Lesley A; Jones, Graham R D; Vassalotti, Joseph A Journal: Clinical chemistry Issue: Volume 65:Number 8(2019) Page Start: 949 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Recommendations for Reporting Low and High Values for Urine Albumin and Total Protein. (1st February 2019) Authors: Miller, W Greg; Bachmann, Lorin M; Fleming, James K; Delanghe, Joris R; Parsa, Afshin; Narva, Andrew S Journal: Clinical chemistry Issue: Volume 65:Number 2(2019) Page Start: 349 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The presence of fructosamine in human aortic valves is associated with valve stiffness. Issue 9 (5th February 2016) Authors: Kishabongo, Antoine S; Katchunga, Philippe; Cikomola, Justin C; De Somer, Filip M; De Buyzere, Marc L; Speeckaert, Marijn M; Delanghe, Joris R Journal: Journal of clinical pathology Issue: Volume 69:Issue 9(2016) Page Start: 772 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗